| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.33B | +23.5% |
| Cost of Revenue | $4.25B | +5.6% |
| Gross Profit | $4.08B | +50.2% |
| R&D Expense | $600.2M | -8.4% |
| SG&A Expense | $343.2M | +12.6% |
| Operating Income | $2.36B | +83.3% |
| Interest Expense | $94.9M | -27.2% |
| Pre-tax Income | $2.36B | +104.0% |
| Income Tax | $458.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.92B | +115.8% |
| Accounts Receivable | $842.3M | +4.1% |
| Inventory | $1.62B | +17.2% |
| Current Assets | $5.73B | +51.5% |
| Total Assets | $11.98B | +24.4% |
| Current Liabilities | $2.06B | +33.6% |
| Long-term Debt | $3.23B | -0.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.63B | +47.8% |
| Capital Expenditures | $1.00B | +126.0% |
| Investing Cash Flow | -$705.4M | +22.9% |
| Financing Cash Flow | -$370.0M | +35.0% |
| Free Cash Flow | $1.63B | +21.7% |
| +212.7% |
| Net Income | $1.90B | +88.4% |
| EPS (Basic) | $4.39 | +85.2% |
| EPS (Diluted) | $4.25 | +87.2% |
| Total Liabilities |
| $5.77B |
| +14.9% |
| Stockholders' Equity | $6.19B | +35.0% |